NSE: PFIZER | BSE: 500680

Mid-range Performer

Download real time

5766.50 438.50 (8.23%)

High volume+gain today

NSE 18 Aug, 2025 3:31 PM (IST)

26,380.4

Market Cap

High in industry

0.3

Beta 1Year

Very Low volatility

Pfizer Ltd. share price target and research reports

Name: Latest research reports of Pfizer Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Pfizer Ltd.
Rating: 4
Author: ICICI Securities Limited

Latest analyst research reports with target prices and PDF download for PFIZER, BSE:500680 Pfizer Ltd.

Search Inside the pdf :

Pfizer Ltd.

31 Oct 2023

5766.50

8.23%

Margins balm the pain of a weak season

Accumulate: Pfizer Ltd.

ICICI Securities Limited

Pfizer’s Q2FY24 revenues declined by 9.8%, marred by a weak season for acute products and the recall of three key brands Magnex, Magnamycin and Zoysn. Gross margins contracted 40bps YoY, but recovered 503bps QoQ to 64.4% as the impact of mandated price cuts on NLEM products was partially offset by better product mix.

Pfizer Ltd. high volume past week with price gain of 15.49.

Pfizer Ltd.

18 Aug 2023, 12:00AM

5766.50

8.23%

Earnings hit by product recall

Accumulate: Pfizer Ltd.

Target

ICICI Securities Limited

Pfizer’s Q1FY24 performance was marred by recall of three key brands - Magnex, Magnamycin and Zoysn. These had annual sales of INR 1.4bn in FY23. Gross margin contracted 420bps YoY at 59.4%, also impacted by mandated price cut on NLEM products.

Pfizer Ltd. is trading above all available SMAs

Pfizer Ltd.

17 May 2023

5766.50

8.23%

Power brands help restore revenue traction

Accumulate: Pfizer Ltd.

Recommendation Target

ICICI Securities Limited

Q4FY23 marked a turnaround in Pfizer’s performance as the declining revenue trend (down 7% in FY23) was arrested in Q4, which saw a 4% YoY rise. The turnaround was driven by traction in key brands such as Magnex, Corex DX, Dolonex, Minipress XL and Prevenar-13.

Pfizer Ltd. is trading above all available SMAs

Pfizer Ltd.

16 May 2023

5766.50

8.23%

Pfizer Ltd

Hold: Pfizer Ltd.

Target

ICICI Direct

Pfizer Ltd.'s price crossed above 50Day SMA today

Pfizer Ltd.

17 Nov 2022

5766.50

8.23%

Pfizer Ltd

Hold: Pfizer Ltd.

Target

ICICI Direct

Pfizer Ltd. has gained 15.49% in the last 1 Week

Pfizer Ltd.

14 Nov 2022

5766.50

8.23%

Stringent cost controls lift margins

Buy: Pfizer Ltd.

Target

ICICI Securities Limited

Pfizer’s Q2FY23 performance beat our estimates on the profitability front driven by strong control over costs. Revenue was flat YoY (+7.5% QoQ) at Rs6.4bn (I-Sec: Rs.6.4bn).

Pfizer Ltd. has gained 38.87% in the last 6 Months

Pfizer Ltd.

08 Aug 2022

5766.50

8.23%

Cost-control supports margins

Buy: Pfizer Ltd.

Target

ICICI Securities Limited

Pfizer’s Q1FY23 performance beat our estimates on the profitability front driven
by strong control over costs. Revenues declined 20.9% YoY (+7.9% QoQ) to Rs 5.9bn (I-Sec: Rs 5.9bn) on a high covid-led base.